Molecular Cloning and Characterization of the Mouse RB1 Promoter
Overview
Authors
Affiliations
We report the isolation and characterization of the mouse RB1 promoter and surrounding DNA sequences, and the identification of elements required for basal transcriptional activity. The mouse RB1 promoter, like the human homologue, has a high G + C content, constitutes a CpG island and is devoid of typical TATA and CAAT boxes. The first 235 base-pairs upstream of the translation initiation codon in the mouse promoter exhibit 80% sequence homology with the human sequence. This homology includes a region which contains putative binding sites for the transcription factors Sp1, ATF and E2F/DRTF1. Four major transcription initiation sites were identified downstream of this conserved region. Mutational analysis revealed that the Sp1 and ATF binding sites, but not the putative E2F/DRTF1 binding site, are critical for promoter activity. Complete disruption of the putative Sp1 and ATF sites abrogated transcription, whereas the introduction of point mutations, previously identified in the Sp1 and ATF sites in two low penetrance retinoblastoma families, reduced promoter activity in a cell type specific manner. Less reduction in activity occurred in retinoic acid induced differentiated P19 cells and NIH3T3 mouse fibroblasts than in undifferentiated embryonal carcinoma P19 cells. Activity of the RB1 promoter was found to be stimulated in retinoic-acid induced differentiated P19 cells compared to undifferentiated P19; this stimulation required intact Sp1 and ATF sites but not the putative E2F/DRTF1 binding site. Our results indicate that basal level of RB1 expression is governed by Sp1 and ATF.
Rosemann M, Gonzalez-Vasconcellos I, Domke T, Kuosaite V, Schneider R, Kremer M Mol Cancer. 2014; 13:182.
PMID: 25092376 PMC: 4237942. DOI: 10.1186/1476-4598-13-182.
Visualizing dynamic E2F-mediated repression in vivo.
Agromayor M, Wloga E, Naglieri B, Abrashkin J, Verma K, Yamasaki L Mol Cell Biol. 2006; 26(12):4448-61.
PMID: 16738312 PMC: 1489115. DOI: 10.1128/MCB.02101-05.
p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme.
Stark A, Witzel P, Strege R, Hugo H, Mehdorn H J Neurol Neurosurg Psychiatry. 2003; 74(6):779-83.
PMID: 12754350 PMC: 1738476. DOI: 10.1136/jnnp.74.6.779.
MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway.
Magenta A, Cenciarelli C, De Santa F, Fuschi P, Martelli F, Caruso M Mol Cell Biol. 2003; 23(8):2893-906.
PMID: 12665587 PMC: 152540. DOI: 10.1128/MCB.23.8.2893-2906.2003.
Integration of the pRB and p53 cell cycle control pathways.
Stewart C, Soria A, Hamel P J Neurooncol. 2001; 51(3):183-204.
PMID: 11407592 DOI: 10.1023/a:1010615822317.